PhishMe® Inc., the leading provider of human phishing defense solutions, today announced that CEO and co-founder Rohyt Belani has been honored as a “CEO of the Year” category winner of the 2016 Info Security Products Guide Global Excellence Awards®.
Accenture (NYSE: ACN) formed a new alliance relationship with Endgame Inc. – a provider of cybersecurity software solutions to actively hunt adversaries – to integrate the company’s sophisticated capabilities with Accenture’s cyber defense services. As part of the relationship, Accenture has also taken an equity position in Endgame. Terms of the investment were not disclosed.
By Sir David Omand First published in the World Policy Journal Winter 2015/2016 LONDON—In 1910, one of the last remaining bands of outlaws of America’s Wild West emerged from their hideout in the Sierra Ladrones Mountains in New Mexico and …
Digital Shadows, the only company to offer organizations cyber situational awareness, today announced that it has closed its Series B funding at $14 million, led by Trinity Ventures, with general partner Fred Wang joining the company’s Board of Directors. Existing investors Storm Ventures, TenEleven Ventures and Passion Capital also participated, and the company also welcomed new investor Paladin Capital Group.
Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the completion of a $61 million Series D private financing. Crossover participants in the round include ARCH Overage Fund, Merieux Developpement, Cormorant Asset Management LLC, Fidelity Management and Research Company and Foresite Capital Management LLC. Additional investors include ARCH Venture Partners, WuXi Healthcare Ventures, Illumina, Inc., Nick and Joby Pritzker (through their family’s firm Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic and additional strategic corporate and venture investors.
With 2015 in the rearview mirror, and 2016 sure to provide new opportunities and challenges, we thought we would share our observations of the past year and the year ahead.